top of page
Search


Putting our lives in their brands
From www.theguardian.com What if brand loyalty was actually as serious as life and death? Nick Dutnall looks at how we might trust a...
Nick Dutnall
3 min read


Making medicine emotional
from www.mmm-online.com Since the birth of branding, and particularly in the advent of the “like,” people have been using brands as a...
Megan Hillen
2 min read


Update on pharmaceutical brand name requirements in Canada
Sponsors filing a drug submission must also provide a brand name assessment as part of the drug safety and effectiveness evaluation. The...
Jennifer McKenzie and Amy Dam / Bereskin &Parr LLP
2 min read

What's in a name? For drugs, a lot of Zs and Xs
Farxiga. Hetlioz. Otezla. Zykadia. No, these are not the names of distant planets visited by the starship Enterprise. They're the brand...
Meg Tirrell | Eric Chemi | Mark Fahey / CBNC
4 min read


Back-to-'Biogen' shift signals wider industry branding trend
Biogen's ($BIIB) recent change back to its original name - from the decade-old merger name Biogen Idec - made sense in many ways. Along...
By Beth Snyder Bulik / FiercePharmaMarketing
2 min read


Cancer breakthroughs trigger big pharma interest in drugs and deals
Companies are scrambling to get into the immunotherapy market, which experts think could eventually be worth up to £26bn a year in sales....
Jennifer Rankin / The Guardian
3 min read


Defining brands and why they are critical to success in healthcare.
As we start our column in earnest, we thought we should perhaps state our position, be clear on some boundaries and definitions of what...
By David Coleiro and Michael White / eye for
5 min read


The Science of Naming Drugs (Sorry, 'Z' Is Already Taken)
Not only is the process of christening a new product a lot trickier than it sounds, the most obvious candidates can be the most perilous....
By Donald G. McNeil Jr. /
4 min read


Biosimilars: Making the most of an “inexact” science
There’s no question that biosimilars are a revolution in life sciences. The development of these complex medications made from living...
by John Phillips, Director
3 min read


India to open drugs database to global regulators
India had exported medicines worth $15.2 billion (about Rs 97,000 crore) in 2014-15, an increase of 5% over the previous year’s figure....
Raji Reddy Kesireddy / ETHealthworld.com
2 min read
bottom of page